Patent: 10,300,185
✉ Email this page to a colleague
Summary for Patent: 10,300,185
| Title: | Guidable intravascular blood pump and related methods |
| Abstract: | An improved intravascular blood pump and related methods involving the broad inventive concept of equipping the intravascular blood pump with guiding features such that the intravascular blood pump can be selectively positioned at a predetermined location within the circulatory system of a patient. |
| Inventor(s): | Walid N. Aboul-Hosn, William R. Kanz, Bruce A. Baker |
| Assignee: | Maquet Cardiovascular LLC |
| Application Number: | US16/153,355 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,300,185
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | XOLAIR | omalizumab | For Injection | 103976 | June 20, 2003 | 10,300,185 | 2038-10-05 |
| Genentech, Inc. | XOLAIR | omalizumab | Injection | 103976 | September 28, 2018 | 10,300,185 | 2038-10-05 |
| Genentech, Inc. | XOLAIR | omalizumab | Injection | 103976 | August 17, 2023 | 10,300,185 | 2038-10-05 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,300,185
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0012148 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0117581 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0154749 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0178807 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9902204 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9959652 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
